Greater Cannabis Company (GCAN) Net Margin (2017 - 2021)
Greater Cannabis Company's (GCAN) quarterly Net Margin came in at 308.5% in Q2 2021, down 260317.0% year-on-year from N/an in Q2 2020, and down 113.44% quarter-over-quarter from 2294.67% in Q2 2020.
Greater Cannabis Company (GCAN) Net Margin (2017 - 2021) Analysis & Trends
Greater Cannabis Company's Net Margin history runs 5 years deep, the most recent figure standing at 308.5% for Q2 2021.
- On a quarterly basis, Net Margin fell 260317.0% year-over-year to 308.5% in Q2 2021; TTM through Dec 2021 was 4768.22%, a 295798.0% decrease from a year earlier, with the FY2021 full-year figure at 4768.22%, down 278843.0% from the prior year.
- Net Margin declined to 308.5% in Q2 2021 per GCAN's latest filing, from 2294.67% in the prior quarter.
- Across five years, Net Margin topped out at 2294.67% in Q2 2020 and bottomed at 45065.75% in Q2 2017.
- The 5-year median for Net Margin is 308.5% (2021), against an average of 11147.95%.
- Across the five-year window, Net Margin jumped 4516509 bps in 2018 and tumbled 2438454 bps in 2019, its largest moves.
- Year by year, Net Margin stood at 28305.15% in 2017, then soared by 100 bps to 28.16% in 2018, then slumped by 86584 bps to 24356.38% in 2019, then jumped by 109 bps to 2294.67% in 2020, then tumbled by 113 bps to 308.5% in 2021.
- Per Business Quant, the three latest GCAN Net Margin figures stand at 308.5% (Q2 2021), 2294.67% (Q2 2020), and 24356.38% (Q4 2019).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 9.29% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 26.57% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -33.66% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 35.18% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 5.03% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 24.30% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 4.16% |
| 10 | Greater Cannabis Company | 292,929.85 | 292,929.85 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -308.50% |
| Jun 30, 2020 | 2,294.67% |
| Dec 31, 2019 | -24,356.38% |
| Sep 30, 2019 | -4,825.57% |
| Dec 31, 2018 | 28.16% |
| Jun 30, 2018 | 99.34% |
| Mar 31, 2018 | 107.62% |
| Sep 30, 2017 | -28,305.15% |
| Jun 30, 2017 | -45,065.75% |